References
- Arlt , A. , Vorndamm , J. , Breitenbroich , M. , Fölsch , U. R. , Kalthoff , H. , Schmidt , W. E. and Schäfer , H. 2001 . Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin . Oncogene , 20 : 859 – 868 .
- Chuang , S. E. , Yeh , P. Y. , Lu , Y. S. , Lai , G. M. , Liao , C. M. , Gao , M. and Cheng , A. L. 2002 . Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells . Biochem. Pharmacol , 63 : 1709 – 1716 .
- Lima , V. , Brito , G. A. , Cunha , F. Q. , Reboucas , C. G. , Falcao , B. A. , Augusto , R. F. , Souza , M. L. , Leitño , B. T. and Ribeiro , R. A. 2005 . Effects of the tumor necrosis factor-α inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters . Eur. J. Oral. Sci , 113 : 210 – 217 .
- Li , J. , Minnich , D. J. , Camp , E. R. , Brank , A. , Mackay , S. L. and Hochwald , S. N. 2006 . Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB . J. Surg. Res , 132 : 112 – 120 .
- Little , J. W. , Falace , D. A. , Miller , C. S. and Rhodus , N. L. 2008 . Dental Management of the Medically Compromised Patient, , 7th ed. , 451 – 452 . St Louis : Mosby .
- Sonis , S. T. 2002 . The biologic role for Nuclear Factor- KappaB in disease and its potential involvement in mucosa injury associated with anti-neoplastic therapy . Crit. Rev. Oral. Biol. Med , 13 : 380 – 389 .
- Sonis , S. T. , Elting , L. S. , Keefe , D. , Peterson , D. E. , Schubert , M. , Hauer-Jensen , M. , Bekele , B. N. , Raber-Durlacher , J. , Donnelly , J. P. and Rubenstein , E. B. 2004 . Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients . Cancer , 100 ( 9 Suppl ) : 1995 – 2025 .
- Wolverton , S. E. 2001 . Comprehensive Dermatologic Drug Therapy, , 4th ed. , 112 125 Philadelphia : WB Saunders .